国际期刊

展开

CANCER BIOLOGY & THERAPY

CANCER BIOLOGY & THERAPY

SCIE,Scopus,DOAJ
期刊简介

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

《CANCER BIOLOGY & THERAPY》期刊已被查看:

此期刊被最新的JCR期刊SCIE收录

期刊关键词

2区 SCIE Scopus DOAJ 医学 4区 ONCOLOGY 肿瘤学

期刊信息
期刊官网:http://www.tandfonline.com/loi/kcbt20#.V4he8kz9cSQ
期刊投稿网址:https://www.editorialmanager.com/CBT
PubMed Central (PMC)链接 :http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1538-4047%5BISSN%5D
通讯地:LANDES BIOSCIENCE, 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, USA, TX, 78701
中国科学院《国际期刊预警名单(试行)》名单
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
此期刊被最新的JCR期刊SCIE收录

版面费 审稿速度 收录数据库 是否oa 研究方向
平均2.3月 SCIE,Scopus,DOAJ NoLetPub与Taylor & Francis签署APC支持服务战略合作协议,选择APC支持服务可享受:多样化支付选项,国税发票,加速发表,京东购物卡福利。了解详情>>> 医学-肿瘤学
中科院分区
大类学科 分区 小类学科 Top期刊 综述期刊
医学 4区 ONCOLOGY
肿瘤学
WOS分区等级:2区
版本 按学科 分区 影响因子
2023-2024年最新版 ONCOLOGY Q2 4.4
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区

上一篇: Elelmiszervizsgalati Kozlemenyek

下一篇:Early Intervention in Psychiatry

发表知识
医学同类期刊